• Home
  • Advanced Research

Advanced Research

BiovaFlex

BiovaFlex

A randomized, double-blind placebo controlled cross-over study published in the Journal of Medicinal Food (Journal of Medicinal Food; September 2015 Volume 18:9 Pages 1042-1048) indicated that taking 450 mg of BiovaFlex® daily was associated with improved Range of Motion (ROM) inparticipant’sneck, back, hips, shoulders, and knees. Increased physical energy and activitywas also reported. The study showed a reduction of lower back pain in 5 days.

Download the full published study here:

Please provide an email address where we should send the download link.

 
 

View a video summary of the BiovaFlex study:

BiovaDerm

BiovaDerm

The open-label study published in Clinical, Cosmetic and Investigational Dermatology (DovePress; 14 October 2016 Volume 2016:9 Pages 357-66) showed daily topical use of BiovaDerm on facial skin significantly reduced the appearance of wrinkles after eight weeks, as measured across three parameters: roughness, contour and depth. This study corroborates results seen in Biova’s prior trial research studies. Further, the researchers point to WSEM’s association with additional mechanisms of cellular activity whereby BiovaDerm might offer natural skin health support and restoration, especially under conditions of oxidative stress, thus contributing to prophylactic anti-aging effects among other applications.

Download the full published study here:

Please provide an email address where we should send the download link.

 
 

View a video summary of the BiovaDerm study:

View a video summary of the BiovaFlex study:

© 2017 Biova® LLC | Privacy Policy

* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

** Details available upon request